Orexo US
Blog

Contact
EN
- EN
- SV

ir@orexo.com
About Us
- About Us
  
  CEO Comments
  
  Objectives & strategies
  
  Financial Information
  
  Board of Directors & Management
  
  Corporate Governance
  
  Career
  
  History
Sustainability
- Sustainability
  
  Focus areas
  
  International framework
  
  Internal policies and guidelines
  
  Sustainability report
Key Therapeutic Areas
- Key Therapeutic Area
Solutions
- Solutions
  
  Commercial Products
  
  Products under Development
  
  Partnerships
Science
- Science
  
  Innovation
  
  Technology
  
  Intellectual Properties
  
  Products under Development
Investors
- Investors
  
  Analysts
  
  Financial calendar & events
  
  ESG sustainable investing
  
  Regulatory Press Releases
  
  Non-regulatory Press Release and News
  
  Reports, presentations and audiocasts
  
  Financial information & key figures
  
  The share
  
  Prospectus
  
  IR contact
  
  Subscription
Media
- Media
  
  Regulatory Press Releases
  
  Press Releases and News
  
  Image bank
  
  Press contact
  
  Subscription
Orexo US
Blog
Contact
EN
- EN
- SV

Orexo
Investors
Financial calendar & events
Interim Report Q3 2022

Interim Report Q3 2022

03 November 2022

Event:	Interim Report Q3 2022
Date:	November 3 2022, at 8 am CET
Contact:	ir@orexo.com

Thanks and welcome back!

Contact | Dictionary & Definitions | Privacy Policy | Legal notice | Cookie policy

Disclaimer

You are now leaving Orexo.com to visit Zubsolv.com a US prescription product site intended for US residents and healthcare professionals. Continue or Return.

Return

Continue

Disclaimer

You are now leaving Orexo.com to visit Rise-us.com a US disease management site intended for US residents and healthcare professionals. Continue or Return.

Return

Continue

Disclaimer

You are now leaving Orexo.com to visit Orexo's US subsidiary Orexo US Inc's website us.orexo.com.

Return

Continue

Disclaimer

This link will take you to a site maintained by a third party who is solely responsible for the content of that site. Orexo provides this link as a service to website visitors. Orexo is not responsible for the privacy policy of any third party websites. We encourage you to read the privacy policy of every website you visit.

Return

Continue

About Us

Sustainability

Key Therapeutic Area

Solutions

Science

Investors

Media

Interim Report Q3 2022